BELKIN Vision Overview

  • Founded
  • 2013

Founded
  • Status
  • Private

  • Employees
  • 20

Employees
  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 12

BELKIN Vision General Information

Description

Developer of noninvasive laser device intended to assist in the treatment of glaucoma. The company offers non-invasive, non-contact, instantaneous, painless, and automated devices offering laser therapy at the click of a button, enabling the medical community and patients to improve treatment outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Primary Office
  • 13 Gan Raveh Street
  • Yavne 8122214
  • Israel
+972 00-000-0000

BELKIN Vision Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BELKIN Vision Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 20-Dec-2021 000.00 Completed Generating Revenue
8. Later Stage VC (Series B) 20-Jul-2020 000.00 000.00 000.00 Completed Generating Revenue
7. Early Stage VC 00000 00.000 00.000 Completed Clinical Trials - General
6. Early Stage VC (Series A) 04-Jun-2017 00.00 00.00 00.000 Completed Clinical Trials - General
5. Grant 04-Jun-2017 00.000 00.00 Completed Clinical Trials - General
4. Seed Round 01-Feb-2016 00.00 00.00 Completed Startup
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator Completed Startup
1. Grant 01-Apr-2013 $600K Completed Startup
To view BELKIN Vision’s complete valuation and funding history, request access »

BELKIN Vision Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B1 Preferred 000,000 00.00 00.00 00 00.00 0.000
B Preferred 0,000,000 00.00 00.00 00 00.00 00.000
A1 Preferred 221,551 $2.48 $2.48 1x $2.48 5.44%
A Preferred 755,287 $3.31 $3.31 1x $3.31 18.55%
To view BELKIN Vision’s complete cap table history, request access »

BELKIN Vision Patents

BELKIN Vision Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021311097-A1 Automated capsulotomy Pending 19-Jul-2020
AU-2020345067-A1 Selective laser stimulation of corneal stem cells Pending 12-Sep-2019 000000000
EP-4028120-A1 Selective laser stimulation of corneal stem cells Pending 12-Sep-2019 000000000
US-20220249861-A1 Selective laser stimulation of corneal stem cells Pending 12-Sep-2019 0000000000
EP-3937867-A1 Automated laser iridotomy Pending 13-Mar-2019 A61F9/00825
To view BELKIN Vision’s complete patent history, request access »

BELKIN Vision Executive Team (9)

Name Title Board Seat Contact Info
Daria Lemann-Bluementhal Co-Founder, Chief Executive Officer & Board Member
Eli Makdasi Chief Operating Officer
Andrew Webb Chief Commercial Officer
Michael Belkin MD Co-Founder & Medical Director
Ziv Karni Ph.D Co-Founder
You’re viewing 5 of 9 executive team members. Get the full list »

BELKIN Vision Board Members (9)

Name Representing Role Since
Andy Corley Self Chairman 000 0000
Da Liu Self Board Member 000 0000
Daria Lemann-Bluementhal BELKIN Vision Co-Founder, Chief Executive Officer & Board Member 000 0000
David Zigdon RAD BioMed Board Member 000 0000
Frank Lee Chen Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

BELKIN Vision Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BELKIN Vision Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
European Innovation Council Fund Venture Capital Minority 000 0000 000000 0
BioLight Life Sciences Venture Capital Minority 000 0000 000000 0
China Resources Capital Management Corporate Venture Capital Minority 000 0000 000000 0
C-Mer Eye Care Corporation Minority 000 0000 000000 0
Santen Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »